Mar 27, 2023 / 12:00PM GMT
Operator
Hello, everyone, and welcome to the Pharming conference call. My name is Nadia, and I will be coordinating the call today. (Operator Instructions) I will now hand over to your host, Dr. Sijmen De Vries, CEO, to begin. Please go ahead.
Sijmen de Vries - Pharming Group N.V. - President, CEO & Executive Director
Thank you very much, and good morning, good afternoon, ladies and gentlemen. On the occasion of the approval of leniolisib, now known under the brand name Joenja. And we're very proud to have achieved this FDA approval, obviously.
Before I go there, I would like to point out to the next slide, about forward-looking statements. As this presentation may contain forward-looking statements, and forward-looking statements are statements of further future expectations that are based upon management's current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements.
And of course, I'll
Pharming Group NV Corporate Analyst Meeting Transcript
Mar 27, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers